INTRODUCTION
============

Despite historical trepidation, there is growing interest in the use of intravitreal injections of chemotherapy for the treatment of retinoblastoma. This has mostly been explored for eyes with vitreous seeding \[[@R1]-[@R8]\], which have notoriously poor rates of globe preservation. While ophthalmic artery chemosurgery has proven to be effective for these eyes (with an ocular survival of 64% in naïve eyes with vitreous seeding only) \[[@R9]\], the use of intravitreal melphalan has a reported initial ocular salvage rate as high as 83%, surpassing all other treatment modalities for eyes that recur or persist despite current treatment modalities \[[@R1],[@R2]\].

However, intravitreal injections disrupt the natural barrier of the eye and there is concern for potential tumor seeding through the needle track. For example, retinoblastoma cells have been detected in the needle track of *ex vivo* post-enucleation specimens \[[@R10],[@R11]\]. Even though the viability of *in vivo* escaped cells is unknown, there are cases of extraocular retinoblastoma disease following both diagnostic and therapeutic intravitreal procedures \[[@R1],[@R2],[@R12],[@R13]\].

Various techniques have been developed to limit the risk of extraocular dissemination when intravitreal injections are given \[[@R1]-[@R3],[@R7],[@R14],[@R15]\]. These methods are intended to prophylactically lower the risk of tumor cell escape, and/or, to target the destruction of leaked cells. The effectiveness of these techniques is unclear and many are not without local repercussions for the eye. We have developed a novel alternative technique, requiring limited sophisticated resources. It consists of submerging the eye in an irrigating reservoir of sterile distilled water in which retinoblastoma cells die. Here we describe this method and offer data that supports its efficacy.

METHODS
=======

Six eyes (1 eye Reese-Ellsworth (RE) Group VA and 5 eyes RE Group VB; 3 eyes International Classification (IC) D and 3 eyes IC E) of six patients (3 male and 3 female, mean age 79 mos (range 17-213 mos)) underwent 20 weekly intravitreal melphalan injections. All patients had bilateral retinoblastoma and 4 were monocular. All eyes had received ophthalmic artery chemosurgery (OAC) and had vitreous seeds refractory to treatment. At the time of injection the patient was positioned supine and digital massage performed to bring the intraocular pressure to less than 10 mmHg confirmed by Tonopen. The eye was then prepped in a sterile fashion, the lashes draped and the lid speculum placed. The injection location in the superior meridian was selected in an area that was free of tumor by ophthalmoscopy and by UBM. At 3.5 mm posterior to the limbus, melphalan 30mcg/0.7cc was injected with a 33-gauge needle. Single freeze-thaw cryotherapy was applied to the ocular surface to seal and sterilize the injection site with an encompassing ice ring, as the needle was withdrawn.

Technique
---------

The necessary equipment is depicted in Fig. (**[1](#F1){ref-type="fig"}**). With the lid speculum in place following injection, sterile distilled water drawn into a 60 cc syringe was lightly irrigated over the eye to fully submerge it in liquid (Fig. **[2](#F2){ref-type="fig"}**). Irrigation with submersion was continued for at least 3 minutes. The effluent was carefully collected into a kidney basin and sent for cytopathological evaluation. Care was taken to place no undue pressure on the eye to prevent efflux of intraocular contents.

*In Vitro* Validation of Principle
----------------------------------

Retinoblastoma cell line Y79 was cultured in RB culture medium consisting of IMDM with 10% FBS (Sigma, St. Louis MO), 1% Penicillin/streptomycin, 2 mM glutamine, 55 μΜ beta-mercaptoethanol (Invitrogen), as described \[[@R16]\], at 37^o^C in a humidified incubator with 5% CO~2~. Mixture of 300 nM 4',6-diamidino-2-phenylindole (DAPI) and 1 mg/ml Propidium Iodide (PI) were prepared in phosphate buffered saline (PBS) or sterile distilled water (dH~2~O). Y79 cells were collected in 1.5 ml Eppendorf tubes with 10^6^ cells per tube. Cells were spun down and medium was removed. 0.5 ml ddiH~2~O or PBS with DAPI/PI was added to Y79 in Eppendorf tube, mixed, and immediately transferred to a hemacytometer. Photographs of DAPI and PI fluorescent staining were taken every half-minute with a fluorescent microscope (Zeiss Imager. Z2). A similar procedure was also carried out for uveal melanoma lines OCM1 and C918.

RESULTS
=======

Cytopathological results revealed no malignant cells in all 20 specimens. There were squamous cells in 3 specimens, red blood cells (RBCs) in 1 specimen and inflammatory cells in 2 specimens. During submersion, all eyes developed clinically apparent cornea edema with stromal haze that resolved approximately one hour later. One injection was accompanied with a subconjunctival hemorrhage, corresponding to the effluent specimen containing RBCs. At a median of 14.8 mos, no tumor growth was observed in the subconjunctival space nor at the needle site.

Results of *in vitro* Y79 cells in sterile distilled deionized water are shown in Fig. (**[3](#F3){ref-type="fig"}**), demonstrating more than 99% of cells were nonviable by 3 minutes. The control group involving Y79 cells in PBS is depicted in Fig. (**[4](#F4){ref-type="fig"}**) and shows more than 80% of cells were still viable by 3 minutes. Both uveal melanoma cells OCM1 and C918 remained viable after immersion in PBS for 20 minutes; and both were approximately 90% nonviable by 10 minutes of immersion in ddiH~2~O.

Comment
-------

The introduction of a needle into a retinoblastoma eye for diagnostic or therapeutic purposes may employ needles of differing sizes (25-27 gauge for fine needle aspiration biopsy (FNAB) \[[@R11]\], and 30-33 gauge for delivery of medication \[[@R17]\]). There is a fear that tumors cells may seed the needle track and disseminate to cause extraocular disease. Reassuringly, we did not discover any malignant cells in our samples of effluent. However, this ominous complication has been reported in scattered cases of reitnoblastoma: Henkes describes a case of extraocular retinoblastoma following FNAB \[[@R13]\], Eide reports on "extraocular drippings" of retinoblastoma with FNAB \[[@R12]\], Makley writes of disease extension through a scleral incision \[[@R18]\] and Kaneko and Susuki have one patient of 237 injected eyes with subconjunctival spread following a therapeutic injection \[[@R2],[@R19]\].

There are techniques to reduce the risk of tumor escape; however, some may have inherent adverse consequences for the eye. For instance, besides scarring, cryotherapy to the injection site (typically at the pars plana) may subject the ciliary body to repetitive, weekly freezing and possibly place the eye at risk for hypotony; an anterior chamber paracentesis may create a transient hypotony but introduces yet another needle in to the eye; and injecting a subtenon deposit of chemotherapy may have similar repercussions to periocular chemotherapy which include transient periorbital edema, pseudocellulitis, fat necrosis, fibrosis, mechanical restriction and optic atrophy \[[@R20]-[@R23]\].

We report on a simple principle validated *in vitro* and translated into a novel precautionary technique for intra-vitreal injection of retinoblastoma eyes. We show that more than 99% of retinoblastoma Y79 cells become nonviable after 3 minutes in sterile distilled water - in contrast to 80% viability at 3 minutes of PBS instillation. The likely explanation is retinoblastoma cell lysis in the hypotonic environment of water, and cell membrane distortion in the presence of a high dielectric constant from dH20. This principle has demonstrated utility in the cell lysis of other tumors \[[@R24]\]. Submerging the eye in sterile distilled water for 3 minutes following intraocular injection, as outlined in this report, should theoretically kill any retinoblastoma cells that may have emerged. Hypothetically, this technique may also be utilized during ophthalmic surgery if an inadvertent penetrating puncture is created. The observed adverse effect was temporary, consisting of transient corneal edema that resolved with time.

Sterile distilled water submersion provides an effective way to kill retinoblastoma cells on the surface of the eye, may be of use during penetrating procedures on affected eyes, requires minimal resources and is easy to replicate.
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![Equipment for the water submersion technique includes a 60 cc syringe, sterile distilled water and a kidney basin.](TOOPHTJ-8-7_F1){#F1}

![Water submersion technique: sterile distilled water is irrigated from 60 cc syringe onto a submerged eye with effluent collecting in kidney basin.](TOOPHTJ-8-7_F2){#F2}

![DAPI (blue) and PI (red) staining of Y79 retinoblastoma cells in sterile distilled deionized water at various time points, demonstrating more than 99% of cells are nonviable by 3 minutes.](TOOPHTJ-8-7_F3){#F3}

![DAPI (blue) and PI (red) staining of Y79 retinoblastoma cells in PBS at various time points, showing more than 80% of cells are still viable by 3 minutes.](TOOPHTJ-8-7_F4){#F4}
